[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:sinonasal-cancer":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Sinonasal Cancer",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07209189","Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)",[11],"Phase 2","RECRUITING","2026-08-26T02:18:55.570428Z","2026-05-05T02:43:28.214027Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07156227","Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma",[19],"Phase 1","2026-08-26T02:17:44.240289Z","2026-06-04T01:30:07.902043Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT05733091","Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors",[],"2026-08-26T02:18:58.141497Z","2026-05-13T02:55:06.373595Z",[],[]]